re: Ann: Collaboration with the MRC Hutchison... Two key points were made:
- Phylomers are viable for phenotypic screening (a much more demanding requirement than genotypic screening). Thus an extreme validation of the complexities of the Phylomer shapes and the appropriateness for phenotype diseases, such as cancers.
- If you can discover an active Phylomer shape ... you can build a Phylomer drug. All the Phylomer chemistry work has demonstrated the ability to adapt a discovered Phylomer activity into a drug compound.
This is very good news. It is the crowning moment in demonstrating the efficacy of Phylomers as biotech designed drugs.
- Forums
- ASX - By Stock
- Ann: Collaboration with the MRC Hutchison Institu
re: Ann: Collaboration with the MRC Hutchison... Two key points...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
IGO
IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity
MND
Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
Add PYC (ASX) to my watchlist
|
|||||
Last
10.3¢ |
Change
-0.003(2.38%) |
Mkt cap ! $461.9M |
Open | High | Low | Value | Volume |
10.0¢ | 10.5¢ | 9.8¢ | $491.0K | 4.887M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 326759 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 640089 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 326759 | 0.100 |
4 | 125087 | 0.099 |
2 | 333147 | 0.098 |
4 | 180468 | 0.097 |
5 | 260211 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 640089 | 6 |
0.110 | 665772 | 10 |
0.115 | 639393 | 6 |
0.120 | 690557 | 7 |
0.125 | 390197 | 4 |
Last trade - 15.10pm 29/07/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |